Tags

Type your tag names separated by a space and hit enter

[Criteria for the use of anti-influenza agents].
Nihon Rinsho. 2003 Nov; 61(11):1963-6.NR

Abstract

Amantadine was used from 1998, and two kinds of neuraminidase inhibitors from 2001, in Japan. These anti-influenza agents were recommended to use within 48 hours after the onset of influenza. Because proliferation of influenza virus reaches to peak after two days of the virus infection and the incubation period is only 24 hours. The patients who are after two days of the onset should be treated by only anti-symptomatic therapies.

Authors+Show Affiliations

National Medical Center.

Pub Type(s)

English Abstract
Journal Article
Review

Language

jpn

PubMed ID

14619439

Citation

Kashiwagi, Seizaburo. "[Criteria for the Use of Anti-influenza Agents]." Nihon Rinsho. Japanese Journal of Clinical Medicine, vol. 61, no. 11, 2003, pp. 1963-6.
Kashiwagi S. [Criteria for the use of anti-influenza agents]. Nihon Rinsho. 2003;61(11):1963-6.
Kashiwagi, S. (2003). [Criteria for the use of anti-influenza agents]. Nihon Rinsho. Japanese Journal of Clinical Medicine, 61(11), 1963-6.
Kashiwagi S. [Criteria for the Use of Anti-influenza Agents]. Nihon Rinsho. 2003;61(11):1963-6. PubMed PMID: 14619439.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Criteria for the use of anti-influenza agents]. A1 - Kashiwagi,Seizaburo, PY - 2003/11/19/pubmed PY - 2004/2/6/medline PY - 2003/11/19/entrez SP - 1963 EP - 6 JF - Nihon rinsho. Japanese journal of clinical medicine JO - Nihon Rinsho VL - 61 IS - 11 N2 - Amantadine was used from 1998, and two kinds of neuraminidase inhibitors from 2001, in Japan. These anti-influenza agents were recommended to use within 48 hours after the onset of influenza. Because proliferation of influenza virus reaches to peak after two days of the virus infection and the incubation period is only 24 hours. The patients who are after two days of the onset should be treated by only anti-symptomatic therapies. SN - 0047-1852 UR - https://www.unboundmedicine.com/medline/citation/14619439/[Criteria_for_the_use_of_anti_influenza_agents]_ L2 - https://medlineplus.gov/flu.html DB - PRIME DP - Unbound Medicine ER -